Skip to main content
. Author manuscript; available in PMC: 2010 Nov 1.
Published in final edited form as: Microb Pathog. 2009 Aug 26;47(5):258–266. doi: 10.1016/j.micpath.2009.08.004

Figure 5.

Figure 5

BNF inhibits the ingestion and intracellular multiplication of L. monocytogenes in AhR-deficient and ARNT-dysfunctional Hepa cells. Hepa-1 (wild type) and AhR-deficient and ARNT-dysfunctional Hepa cells were treated with DMSO or BNF (10 μM) for 5 h before being infected with 105 log-phase L. monocytogenes for 2 h (Ingestion). Cells were then washed extensively to remove extracellular Listeriae and incubated in media with 5 μg/mL gentamycin for 8 h. Cells were then lysed in sterile H2O to determine the CFU of L. monocytogenes. Data illustrate the mean±SEM Log10CFU/mL of three separate experiments that were performed. *: p<0.05, as compared to the corresponding controls. A. BNF (Inline graphic) inhibited the ingestion and intracellular growth of L. monocytogenes in the WT Hepa-1 cells at all the times tested as compared to the DMSO control (Inline graphic). B. The inhibitory effects of BNF on L. monocytogenes persist as seen in AhR-deficient and ARNT-dysfunctional Hepa cells. Used symbols indicate: Inline graphic: Ingestion, DMSO control; Inline graphic: Ingestion, BNF (10 μM); Inline graphic: 8 h, DMSO control; Inline graphic: 8 h, BNF (10 μM).